Baltimore, MDNCT04078230Now EnrollingIRB Ready

Intrahepatic Cholangiocarcinoma Clinical Trial in Baltimore, MD

Access cutting-edge intrahepatic cholangiocarcinoma treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access intrahepatic cholangiocarcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related intrahepatic cholangiocarcinoma treatment provided free

Apply for This Baltimore Location

Check if you qualify for this intrahepatic cholangiocarcinoma clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This Intrahepatic Cholangiocarcinoma Study in Baltimore

Intrahepatic cholangiocarcinoma (ICC) is one of the common malignant tumors. Lymph node metastasis is an important factor affecting the poor prognosis of intrahepatic cholangiocarcinoma. The eighth edition of the AJCC guidelines recommends at least 6 lymph nodes to be used for staging. The American Hepatobiliary and Pancreatic Association also recommends the removal of hilar lymph nodes as part of the radical surgery for intrahepatic cholangiocarcinoma. However, some scholars have found that patients with regional lymph nodes have similar survival rates. This contradictory result has prompted more scholars to conduct clinical research to explore the necessity and standardization of lymph node dissection in intrahepatic cholangiocarcinoma.

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Who Can Participate

Inclusion Criteria

Patients \>18 years of age and ≤80 years of age;
Preoperative imaging and laboratory examination for intrahepatic cholangiocarcinoma, intraoperative frozen and postoperative pathology confirmed as intrahepatic cholangiocarcinoma; preoperative imaging assessment is resectable;
No obvious lymph node metastasis in preoperative imaging; or negative intraoperative lymph node biopsy
Liver function Child-Turcotte-Pugh score A-B grade;
Residual liver volume \>30%; can tolerate radical hepatectomy
The patient has autonomy, understands and voluntarily signs the written informed consent and is able to complete the follow-up plan;
Sign the written informed consent form prior to the test screening.

Exclusion Criteria

The patient has obvious heart, lung, brain and kidney dysfunction that affects the treatment of intrahepatic cholangiocarcinoma;
The patient has a history of other malignant tumors;
Liver function Child-Turcotte-Pugh score C;
The investigator determined that it was not suitable for the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT04078230) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Intrahepatic Cholangiocarcinoma Treatment Options in Baltimore, MD

If you're searching for intrahepatic cholangiocarcinoma treatment options in Baltimore, MD, this clinical trial (NCT04078230) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced intrahepatic cholangiocarcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all intrahepatic cholangiocarcinoma clinical trials near you to find additional studies recruiting in your area.

More Liver Cancer Trials in Baltimore, MD

See all liver cancer clinical trials recruiting in Baltimore — not just this study.

Browse Liver Cancer Trials in Baltimore →

Browse More Trials by Condition

Liver Cancer TrialsGallbladder Cancer TrialsRheumatoid Arthritis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD